Literature DB >> 31899069

Flu vaccine coverage for recommended populations in France.

J Robert1, B Detournay2, M C Levant3, M Uhart3, J Gourmelen4, J M Cohen5.   

Abstract

OBJECTIVES: To estimate the size of the populations targeted by the French recommendations of the High Council for Public Health (French acronym HCSP) regarding vaccination against seasonal flu and to estimate vaccination coverage rates in these populations. PATIENTS AND METHODS: The analysis was conducted on a representative sample of patients retrieved from the French Health Insurance databases during three influenza seasons (2012-2013, 2013-2014, 2014-2015). Patients targeted by the influenza vaccination recommendations were identified based on their sociodemographic characteristics and disease identification algorithms during each season. Vaccine coverage rates were estimated based on reimbursed influenza vaccines. Results were extrapolated using indirect standardization to the overall French population.
RESULTS: Populations targeted by the recommendations were estimated after extrapolation to 17.6, 17.8, and 18.0 million for the 2012-13, 2013-14, and 2014-15 influenza seasons, respectively. The vaccination coverage rates in these target populations were respectively estimated at 32.1%, 31.9%, and 32.1%; i.e. 44.2%, 43.1%, and 42.7% for individuals aged ≥65 years and 12.9%, 13.2%, and 13.7% for individuals ˂65 years of age presenting a risk justifying vaccination.
CONCLUSIONS: Immunization coverage against influenza in France remains well below the target of 75% set by the World Health Organization. Multiple strategies combining communication, education, access program, and professional engagement could be implemented to improve this situation.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Influenza; Influenza vaccines; Vaccination coverage

Year:  2019        PMID: 31899069     DOI: 10.1016/j.medmal.2019.12.004

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  5 in total

1.  The Health Professional's View on the Inclusion of Age in the Recommendations for Pneumococcal Vaccination: Results of a Cross-Sectional Survey in France.

Authors:  Gaëlle Farge; Benoît de Wazières; Jocelyn Raude; Clémence Delavelle; Fabienne Humbert; Cécile Janssen
Journal:  Geriatrics (Basel)       Date:  2021-12-23

Review 2.  Antigenic characterization of influenza and SARS-CoV-2 viruses.

Authors:  Yang Wang; Cynthia Y Tang; Xiu-Feng Wan
Journal:  Anal Bioanal Chem       Date:  2021-12-14       Impact factor: 4.142

3.  Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors.

Authors:  Ignacio Hernández-García; Moisés Garcés-Redondo; Joana Rodríguez-Montolio; Irantzu Bengoa-Urrengoechea; Judit Espinosa-Rueda; Carlos Aibar-Remón
Journal:  Vaccines (Basel)       Date:  2022-07-21

Review 4.  Nurses' Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature.

Authors:  Natacha Pinatel; Catherine Plotton; Bruno Pozzetto; Xavier Gocko
Journal:  Vaccines (Basel)       Date:  2022-06-22

5.  Covid-19 pandemic: an opportunity to seize to increase awareness and vaccine coverage in at-risk populations.

Authors:  Paul Loubet; Albert Sotto
Journal:  Hum Vaccin Immunother       Date:  2021-06-07       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.